US judge blocks WuXi AppTec military listing, shielding $43B firm

A federal judge blocked the Pentagon from designating WuXi AppTec as a Chinese military company, shielding the $43 billion biotech from contract restrictions that take effect this month.

A U.S. judge barred the Pentagon from listing WuXi AppTec as a Chinese military company, ruling the government lacked evidence for a designation that had already cost the $43 billion biotech contracts and customers.

"A scarlet letter sends a clear message: keep away," U.S. District Judge James Boasberg wrote in the order, noting that WuXi's customers and suppliers had canceled contracts, terminated longstanding relationships and moved business to competitors since the June designation.

WuXi told the court it employs roughly 450 people in the United States and serves more than 1,000 U.S. customers, with U.S. customers accounting for roughly 70 percent of its revenue last year. A majority of its board and executive managers are U.S. citizens. The company's lawsuit called the designation arbitrary, capricious, unsupported by the facts and "the product of political pressure."

The Pentagon expanded its blacklist to 188 companies in June, reflecting concern that China's military could tap the country's private sector for advancements as geopolitical tensions between Beijing and Washington run high. Under recent U.S. law, the Defense Department cannot contract with listed companies starting later this month, and cannot buy their products or services via third parties beginning in 2027.

The ruling is the latest legal challenge to a list that companies say carries reputational and commercial damage even without formal sanctions. Other businesses added in June include e-commerce company Alibaba, internet search company Baidu and automakers BYD and NIO. The list is updated at least annually, and businesses can petition for removal.

Founded in 2000, WuXi provides research, development and manufacturing services to more than 4,000 pharmaceutical and life-sciences companies, including more than 1,200 customers in the United States. Its market value is about $43 billion, according to Reuters data. The company's U.S. footprint — roughly 450 employees and a board and executive team that is majority U.S. citizens — formed the core of its argument that the designation was unjustified.

The Pentagon's list, created under a 1999 law and expanded repeatedly, has become a flashpoint in U.S.-China commercial relations as Washington seeks to limit Beijing's access to advanced technology. The June expansion to 188 companies was among the largest single additions, sweeping in household names across e-commerce, search and electric vehicles.

What the ruling means for WuXi and its peers

The decision could ease investor concerns about sanctions on WuXi and other Chinese companies facing similar military-linked designations, potentially supporting valuations as the Pentagon weighs future additions. For WuXi, the ruling removes a near-term barrier to U.S. government contracting, though the Pentagon could appeal or seek to re-designate the company with additional evidence.

The broader list expansion points to a tightening regulatory environment for Chinese firms with U.S. exposure. WuXi's heavy reliance on U.S. customers — roughly 70 percent of revenue — makes the designation particularly consequential, as inclusion would have barred the Defense Department from contracting with the company starting this month and from buying its services through third parties from 2027. The outcome may also influence how other listed companies, including Alibaba and BYD, approach their own challenges to the designation.

This article is for informational purposes only and does not constitute investment advice.